Jonquailine, a new pretazettine-type alkaloid isolated from Narcissus jonquilla quail, with activity against drug-resistant cancer

Fitoterapia

Volumn 102, Issue , 2015, Pages 41-48

  Masi, Marco ^a   Frolova, Liliya V ^b   Yu, Xiaojie ^c   Mathieu, Véronique ^d   Cimmino, Alessio ^a   De Carvalho, Annelise ^d   Kiss, Robert ^d   Rogelj, Snezna ^b   Pertsemlidis, Alexander ^c   Kornienko, Alexander ^e   Evidente, Antonio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NEW MEXICO INSTITUTE OF MINING AND TECHNOLOGY   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^e Texas State University   (United States)

Author keywords

Alkaloids; Amaryllidaceae; Antiproliferative effects; Cancer cells; Jonquailine; Narcissus jonquilla quail

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; JONQUAILINE; PACLITAXEL; PODOPHYLLOTOXIN; PRETAZETTINE; UNCLASSIFIED DRUG; VINBLASTINE; ALKALOID; AMARYLLIDACEAE ALKALOID;

A549 CELL LINE; ACETALIZATION; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYSIS; CIRCULAR DICHROISM; DRUG DETERMINATION; DRUG HYDROXYLATION; DRUG ISOLATION; DRUG POTENTIATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; GLIOBLASTOMA CELL LINE; HETERONUCLEAR MULTIPLE BOND CORRELATION; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HUMAN; HUMAN CELL; HYDROXYLATION; MELANOMA CELL LINE; MULTIDRUG RESISTANCE; NARCISSUS; NARCISSUS JONQUILLA QUAIL; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; UTERUS SARCOMA; CHEMICAL STRUCTURE; CHEMISTRY; DRUG RESISTANCE; ISOLATION AND PURIFICATION; PLANT ROOT; TUMOR CELL LINE;

AMARYLLIDACEAE; NARCISSUS JONQUILLA; PHASIANIDAE;

ALKALOIDS; AMARYLLIDACEAE ALKALOIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HUMANS; MOLECULAR STRUCTURE; NARCISSUS; PLANT ROOTS;

EID: 84923328156     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2015.01.009     Document Type: Article

References (56)

1. S.H. Kaufmann, and W.C. Earnshaw Induction of apoptosis by cancer chemotherapy Exp Cell Res 256 2000 42 49
2. A. Kornienko, V. Mathieu, S. Rastogi, F. Lefranc, and R. Kiss Therapeutic agents triggering nonapoptotic cancer cell death J Med Chem 56 2013 4823 4839
3. P. Savage, J. Stebbing, M. Bower, and T. Crook Why does cytotoxic chemotherapy cure only some cancers? Nat Clin Pract Oncol 6 2009 43 52
4. T.R. Wilson, P.G. Johnston, and D.B. Longley Anti-apoptotic mechanisms of drug resistance in cancer Curr Cancer Drug Targets 9 2009 307 319
5. H. Brenner Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis Lancet 360 2002 1131 1135
6. C.D. Simpson, K. Anyiwe, and A.D. Schimmer Anoikis resistance and tumor metastasis Cancer Lett 272 2008 177 185
7. A. Giese, R. Bjerkvig, M.E. Berens, and M. Westphal Cost of migration: invasion of malignant gliomas and implications for treatment J Clin Oncol 21 2003 1624 1636
8. G. Van Goietsenoven, A. Andolfi, B. Lallemand, A. Cimmino, D. Lamoral-Theys, and T. Gras Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells J Nat Prod 73 2010 1223 1227
9. D. Lamoral-Theys, A. Andolfi, G. Van Goietsenoven, A. Cimmino, B. Le Calvé, and N. Wauthoz Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight J Med Chem 52 2009 6244 6256
10. N.M. Evdokimov, D. Lamoral-Theys, V. Mathieu, A. Andolfi, S. Pelly, and W.A.L. van Otterlo In search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivatives Bioorg Med Chem 19 2011 7252 7261
11. G. Luchetti, R. Johnston, V. Mathieu, F. Lefranc, K. Hayden, and A. Andolfi Bulbispermine: a crinine-type Amaryllidaceae alkaloid exhibiting cytostatic activity toward apoptosis-resistant glioma cells ChemMedChem 7 2012 815 822
12. I.I. Budihardjo, S.A. Boerner, S. Eckdahl, P.A. Svingen, R. Rios, and M.M. Ames Effect of 6-aminonicotinamide and other protein synthesis inhibitors on formation of platinum-DNA adducts and cisplatin sensitivity Mol Pharmacol 57 2000 529 583
13. F. Robert, M. Carrier, S. Rawe, S. Chen, S. Lowe, and J. Pelletier Altering chemosensitivity by modulating translation elongation PLoS One 4 2009 e5428
14. M. Wetzler, and D. Segal Omacetaxine as an anticancer therapeutic: what is old is new again Curr Pharm Des 17 2011 59 64
15. R. Cencic, F. Robert, G. Galicia-Vazquez, A. Malina, K. Ravindar, and R. Somaiah Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A Blood Cancer J 3 2013 e128
16. M.M. Gottesman, T. Fojo, and S.E. Bates Multidrug resistance in cancer: role of ATP-dependent transporters Nat Rev Cancer 2 2002 48 58
17. M. Saraswathy, and S.Q. Gong Different strategies to overcome multidrug resistance in cancer Biotechnol Adv 31 2013 1397 1407
18. G.K. Chen, G.E. Duran, A. Mangili, L. Beketic-Oreskovic, and B.I. Sikic MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells Br J Cancer 83 2000 892
19. R. Geney, M. Ungureanu, D. Li, and I. Ojima Overcoming multidrug resistance in taxane chemotherapy Clin Chem Lab Med 40 2002 918 925
20. L.V. Frolova, I.V. Magedov, A.E. Romero, M. Karki, I. Otero, and K. Hayden Exploring natural product chemistry and biology with multicomponent reactions. 5. Discovery of a novel tubulin-targeting scaffold derived from the rigidin family of marine alkaloids J Med Chem 56 2013 6886 6900
21. D.J. Newman, and G.M. Cragg Natural products as sources of new drugs over the 30 years from 1981 to 2010 J Nat Prod 75 2012 311 335
22. J.L. Hartwell Plants used against cancer. A survey Lloydia 30 1967 379 436
23. A. Kornienko, and E. Evidente Chemistry, biology, and medicinal potential of narciclasine and its congeners Chem Rev 108 2008 1982 2014 [and references cited therein]
24. S.F. Martin The Amaryllidaceae alkaloids A.R. Brossi, The Alkaloids 1987 Academic Press New York 251 376
25. O. Hoshino The Amaryllidaceae alkaloids G.A. Cordell, The Alkaloids 1998 Academic Press London 323 376
26. J.W. Cook, and J.D. Loudon R.H.F. Manske, H.L. Holmes, The Alkaloids 1952 Academic Press New York 331 360
27. G. Ceriotti Narciclasine: an antimitotic substance from Narcissus bulbs Nature 213 1967 595 596
28. G. Van Goietsenoven, V. Mathieu, F. Lefranc, A. Kornienko, A. Evidente, and R. Kiss Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers Med Res Rev 33 2013 439 455
29. A. Jimenez, A. Santos, G. Alonso, and D. Vazquez Inhibitors of protein synthesis in eukaryotic cells: comparative effects of some Amaryllidaceae alkaloids Biochim Biophys Acta 425 1976 342 348
30. A. Jimenez, L. Sanchez, and D. Vazquez Yeast ribosomal sensitivity and resistance to the Amaryllidaceae alkaloids FEBS Lett 60 1975 66 70
31. G.R. Ebrahimian, X.M. du Jourdin, and P.L. Fuchs Jacobsen protocols for large-scale epoxidation of cyclic dienyl sulfones: application to the (+)-pretazettine core Org Lett 14 2012 2630 2633 [and references cited therein]
32. W.C. Wildman, and D.T. Bailey Pretazettine J Am Chem Soc 89 1967 5514 5515
33. E. Furusawa, H. Irie, D. Combs, and W.C. Wildman Therapeutic activity of pretazettine on Rauscher leukemia: comparison with the related Amaryllidaceae alkaloids Chemotherapy 26 1980 36 45
34. E. Furusawa, R.H. Lockwood, S. Furusawa, M.K.M. Lum, and J.Y.B. Lee Therapeutic activity of Pretazettine, a narcissus alkaloid, on spontaneous AKR leukemia Chemotherapy 25 1979 308 315
35. E. Furusawa, M.K.M. Lum, and S. Furusawa Therapeutic activity of pretazettine on Ehrlich ascites carcinoma: adjuvant effect on standard drugs in ABC regimen Chemotherapy 27 1981 277 286
36. E. Furusawa, and L. Sokugawa Therapeutic activity of pretazettine, standard drugs, and the combinations on intraperitoneally implanted Lewis lung carcinoma in mice Chemotherapy 29 1983 294 302
37. R. Gotti, J. Fiori, M. Bartolini, and V. Cavrini Analysis of Amaryllidaceae alkaloids from Narcissus by GC-MS and capillary electrophoresis J Pharm Biomed Anal 42 2006 17 24
38. S. Berger, and S. Braun 200 and more basic NMR experiments: a practical course 1st ed. 2004 Wiley-VCH Weinheim
39. F. Cabezas, A. Ramírez, F. Viladomat, C. Codina, and J. Bastida Alkaloids from Eucharis amazonica (Amaryllidaceae) Chem Pharm Bull 51 2003 315 317 [and literatures therein cited]
40. J. Wagner, H.L. Pham, and W. Döpke Alkaloids from Hippeastrum equestre Herb. - 5. Circular dichroism studies Tetrahedron 52 1996 6591 6600
41. T.H. Kinstle, W.C. Wildman, and C.L. Brown Mass spectra of Amaryllidaceae alkaloids. Structure of narcissidine Tetrahedron Lett 39 1966 4659 4666
42. T. Ibuka, H. Irie, A. Kato, S. Uyeo, K. Kotera, and Y. Nakagawa Mass spectrometry of Amaryllidaceae alkaloids Tetrahedron Lett 39 1966 4745 4748
43. C.I. Bliss The toxicity of poisons applied jointly Ann Appl Biol 26 1939 585 615
44. W.G. Harker, and B.I. Sikic Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA Cancer Res 45 1985 4091 4096
45. 13C NMR analysis of lycorine and α-dihydrolycorine Phytochemistry 22 1983 581 584
46. E. Pretsch, P. Bühlmann, and C. Affolter Structure determination of organic compounds - tables of spectral data 3rd ed. 2000 Springer-Verlag Berlin 161 243
47. E. Breitmaier, and W. Voelter Carbon-13 NMR spectroscopy 1987 VCH Weinheim 183 280
48. F.M. Zhang, Y.Q. Tu, J.D. Liu, X.H. Fan, L. Shi, and X.D. Hu A general approach to crinine-type Amaryllidaceae alkaloids: total syntheses of (±)-haemanthidine, (±)-pretazettine, (±)-tazettine and (±)-crinamine Tetrahedron 62 2006 9446 9455
49. W.C. Wildman, and D.T. Bailey Novel alkaloids containing the [2] benzopyrano [3, 4-c] indole nucleus J Org Chem 33 1968 3749 3753
50. J.P. de Andrade, N.B. Pigni, L. Torras-Claveria, S. Berkov, C. Codina, and F. Viladomat Bioactive alkaloid extracts from Narcissus broussonetii: mass spectral studies J Pharm Biomed Anal 70 2012 13 25
51. F. Branle, F. Lefranc, I. Camby, J. Jeuken, A. Geurts-Moespot, and S. Sprenger Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy Cancer 95 2002 641 655
52. J. Li, W. Hu, and Q. Lan The apoptosis-resistance in t-AUCB-treated glioblastoma cells depends on activation of Hsp27 J Neurooncol 110 2012 187 194
53. A. Mathieu, M. Remmelink, N. D'Haene, S. Penant, J.F. Gaussin, and R. Van Ginckel Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice Cancer 101 2004 1908 1918
54. V. Mathieu, C. Pirker, E. Martin de Lasalle, M. Vernier, T. Mijatovic, and N. De Neve The sodium pump α1 sub-unit: a disease progression-related target for metastatic melanoma treatment J Cell Mol Med 13 2009 3960 3972
55. F. Lefranc, G. Nuzzo, N.A. Hamdy, I. Fakhr, Y. Moreno, and L. Banuls In vitro pharmacological and toxicological effects of norterpene peroxides isolated from the Red Sea sponge Diacarnus erythraeanus on normal and cancer cells J Nat Prod 76 2013 1541 1547
56. O. Mayba, F. Gnad, M. Peyton, F. Zhang, K. Walter, and P. Du Integrative analysis of two cell lines derived from a non-small-lung cancer patient - a panomics approach Pac Symp Biocomput 2014 75 86